This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated HSF1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HSF1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~57.3 kDa | |
| Observed band | ~80 kDa | |
| Gel | 5–20% (catalog M00250-1) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The M00250-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human Hela, human MCF-7, human K562 (catalog M00250-1) |
| Gel % | 5–20% (catalog M00250-1) |
| Load | 30 ug; reducing conditions (catalog M00250-1) |
| Transfer | a nitrocellulose membrane at 150 mA for 50-90 minutes (catalog M00250-1) |
| Membrane | nitrocellulose membrane (catalog M00250-1) |
| Blocking | 5% non-fat milk/TBS for 1.5 hour at RT (catalog M00250-1) |
| Primary antibody | M00250-1 · 1:500 (catalog M00250-1) |
| Primary incubation | overnight at 4°C (catalog M00250-1) |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 (catalog M00250-1) |
| Secondary incubation | 1.5 hour at RT (catalog M00250-1) |
| Wash | TBS-0.1%Tween 3 times with 5 minutes each (catalog M00250-1) |
| Detection | ECL (catalog M00250-1) |
HSF1 is predicted at 57.3 kDa, but an empirical band appears near 80 kDa; the cause of that difference is not established.
| Band near 80 kDa | Empirical HSF1 band in reducing whole-cell lysates; identity warrants confirmation |
| Band near 57.3 kDa | Near the sequence-predicted mass; identity remains unconfirmed |
| Several bands at different positions | Long and Short isoforms could contribute, but distinct migration is unverified |
| Weak nuclear-fraction band in unstressed cells | Unstressed HSF1 is described as a latent cytoplasmic monomer |
| Predicted 57.3 kDa mass | Sequence-based reference; the empirical band is ~80 kDa, with the difference unexplained |
| Long isoform | May have a different mass from Short; its migration is not supplied |
| Short isoform | May have a different mass from Long; its migration is not supplied |
| Long and Short splice isoforms | Could yield more than one band, but a resolvable difference is unverified |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | The ~80 kDa empirical band exceeds the 57.3 kDa prediction for an unestablished reason | Check an HSF1 knockdown and a second antibody |
| Band lower than expected | The Short isoform is a possible contributor, but its migration is unknown | Confirm identity with knockdown and isoform-aware controls |
| Multiple bands | Long and Short isoforms are possible contributors; other bands may be nonspecific | Compare bands after HSF1 knockdown and with a second antibody |
| Weak or no signal | Unstressed HSF1 is described as a latent cytoplasmic monomer, which may limit a nuclear-fraction signal | Compare nuclear and cytoplasmic fractions and include a positive control |
| Fragments below expected size | Protein breakdown during sample handling is possible; no HSF1 cleavage product is specified | Prepare fresh samples with protease inhibitors and verify bands with a second epitope |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Breast | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | cells in molecular layer | High | Protein (IHC) | HPA → |
| Cerebral cortex | neuronal cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | Low | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Low | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Medium | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Medium | Protein (IHC) | HPA → |
| Caudate | glial cells | Medium | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for HSF1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
All four antibodies list human reactivity and have WB images. The HSF1 captions report bands near 80 kDa despite a stated 57 kDa expected size. The images document specific cell lysates; they do not establish performance across all human samples.
Which to pick: For total HSF1, M00250-1 and A00250 show WB results in human cell lysates. For phospho-S326, A00250S326 shows HeLa, BT20, and AGS controls. P00250 is labeled phospho-S326, but its WB caption describes HSF1 without phosphorylation-specific evidence.